Axelpharm demands a license for anti-cancer drug from AstraZeneca
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...
Despite statements by international pharmaceutical companies about the suspension of new trials in Russia after the outbreak of hostilities in...